Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | PKM | P14618 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ILK | Q13418 | 1/20 | 0.50 |
| ▸ | AHR | P35869 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30421999 | 1.00 | SMN1; SMN2 (0.57) | SMN1; SMN2NPC1RAB9AHSD17B10PKM | |
| SCHEMBL13862697 | 0.85 | TRPV1 (0.52) | SMN1; SMN2NPC1RAB9AHSD17B10PKM | |
| SCHEMBL2615304 | 0.84 | SMN1; SMN2 (0.61) | SMN1; SMN2NPC1RAB9AHSD17B10PKM | |
| SCHEMBL31036744 | 0.84 | SMN1; SMN2 (0.61) | SMN1; SMN2NPC1RAB9AHSD17B10PKM | |
| SCHEMBL2615303 | 0.84 | SMN1; SMN2 (0.61) | SMN1; SMN2NPC1RAB9AHSD17B10PKM | |
| SCHEMBL11153027 | 0.81 | ALDH1A1 (0.55) | SMN1; SMN2NPC1RAB9AHSD17B10PKM | |
| SCHEMBL92781 | 0.79 | SMN1; SMN2 (0.61) | SMN1; SMN2NPC1RAB9AHSD17B10PKM | |
| SCHEMBL4920329 | 0.79 | TRPV1 (0.65) | SMN1; SMN2NPC1RAB9APKMTP53 | |
| Bromide SCHEMBL10996884 | 0.78 | SMN1; SMN2 (0.59) | SMN1; SMN2NPC1RAB9AHSD17B10PKM | |
| SCHEMBL2432396 | 0.78 | F2RL3 (0.51) | SMN1; SMN2NPC1RAB9APKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118355041-A | Method for underwater bonding | 汉高股份有限及两合公司 | 2024-07-16 | — | — | CN | claimed |
| CN-113045993-A | Polishing solution for processing ultra-smooth low-damage bearing steel surface and application thereof | 西南交通大学 | 2021-06-29 | — | — | CN | claimed |
| EP-3464446-B1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | Henkel IP & Holding GmbH (DE) | 2021-06-23 | — | — | EP | claimed |
| CN-109476874-B | Two-part cyanoacrylate curable adhesive systems | 汉高知识产权控股有限责任公司 | 2021-04-16 | — | — | CN | claimed |
| US-10655015-B2 | Tire crumb-based bitumen polymer for producing a lower viscosity asphalt with improved tolerance to high temperatures | Argopro Group LLC (US) | 2020-05-19 | — | — | US | claimed |
| US-20200095424-A1 | TIRE CRUMB-BASED BITUMEN POLYMER FOR PRODUCING A LOWER VISCOSITY ASPHALT WITH IMPROVED TOLERANCE TO HIGH TEMPERATURES | Argopro Group LLC | 2020-03-26 | — | — | US | claimed |
| EP-3464446-A1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | Henkel IP & Holding GmbH (DE) | 2019-04-10 | — | — | EP | claimed |
| US-10100235-B2 | Two-part cyanoacrylate curable adhesive system | Henkel IP & Holding GmbH (DE) | 2018-10-16 | — | — | US | claimed |
| WO-2017202698-A1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | Henkel IP & Holding GmbH (DE) | 2017-11-30 | — | — | WO | claimed |
| US-20170335151-A1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | HENKEL AG & CO. KGAA (DE) | 2017-11-23 | — | — | US | claimed |
| EP-2346956-A1 | ACTIVATORS FOR TWO PART CYANOACRYLATE ADHESIVES | Loctite (R & D) Limited (IE) | 2011-07-27 | — | — | EP | claimed |
| WO-2010046412-A1 | ACTIVATORS FOR TWO PART CYANOACRYLATE ADHESIVES | LOCTITE (R & D) LIMITED (IE) | 2010-04-29 | — | — | WO | claimed |
| EP-4732907-A1 | STYRYL BENZOTHIAZOLIUM SALTS AND ITS USES AGAINST PARASITIC INFECTIONS | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2026-04-29 | — | — | EP | disclosed |
| EP-4219460-B1 | TRANSGLUTAMINASE 2 (TG2) INHIBITORS | SITARI PHARMA INC (US) | 2025-02-26 | — | — | EP | disclosed |
| CN-119522221-A | Cyanine dye, preparation method and application thereof, sample analysis method and analyzer | 深圳迈瑞生物医疗电子股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| US-20250011324-A1 | TRANSGLUTAMINASE 2 (TG2) INHIBITORS | SITARI PHARMA, INC., | 2025-01-09 | — | — | US | disclosed |
| EP-0545380-A1 | Silver halide emulsions spectrally sensitized to infrared radiation with novel cyanine dyes | POLAROID CORPORATION (US) | 1993-06-09 | — | — | EP | disclosed |
| EP-0533695-A1 | IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY. | PFIZER (US) | 1993-03-31 | — | — | EP | disclosed |
| CN-1057839-A | The azepine benzoglyoxaline that is used for the treatment of asthma, sacroiliitis and relative disease | PFIZER (US) | 1992-01-15 | — | — | CN | disclosed |
| WO-1991017163-A1 | IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY | PFIZER INC. (US) | 1991-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250011324-A1 | TRANSGLUTAMINASE 2 (TG2) INHIBITORS | TGM2, TGM3, TGM1 | SMN1; SMN2 2176/4885NPC1 3220/4885RAB9A 2492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.